Quality indicators and the Japanese lung cancer registry

Takahiro Higashi, Hisao Asamura

Research output: Contribution to journalArticle

Abstract

Quality of care has been recognized as a national issue in Japan, particularly in the area of cancer care. The Cancer Control Act of 2006 states that the government should take action to assure quality of care throughout Japan. The Interim Report on the Cancer Control Plan, published in 2010, reviewed current activities and stated the need for a Quality Benchmarking Center to monitor the quality of cancer care using process-of-care quality indicators derived from clinical practice guidelines. Recognizing this national concern, a research project is under way to develop process-of-care quality indicators for 5 major types of cancer in Japan, including lung cancer. The process involved the identification of potential quality indicators and the examination of their validity using the modified Delphi method by a panel of multidisciplinary clinical experts. For lung cancer, this process produced 35 quality indicators covering a broad range of care, including pre-treatment evaluation, surgical treatment chemotherapy and radiation therapy. Although these quality indicators are designed to be implemented based on medical records, some quality indicators were apparently scorable using data from the Japanese Lung Cancer Registry operated by the Japanese Joint Committee for Lung Cancer Registry. If such usage is possible, systematic quality monitoring and feedback could be provided to the participating facility in order to improve quality of care. Further, feedback on care quality in an individual hospital, without disclosing the information to a third party can be regarded as a benefit of participation. However, detailed examination revealed that 6 out of 7 quality indicators that appeared to be theoretically scorable using registry data examined the presence/absence of the documentation of necessary clinical information in patient medical records. Therefore, for the scores to validly represent quality, we must assume that the existence of information in the examined data sets means that the pertinent documentation is also present in the medical records. Because we do not know whether this assumption is reasonable, we concluded that the current database is insufficient for quality of care monitoring. The current Lung Cancer Registry primarily aims to provide data to determine the TNM staging system, limiting the extent of available information in order to avoid placing an excessive burden on participating institutions. If we are to expand its scope to include quality improvement of lung cancer care in the future, the linking of data with other systems such as administrative databases and hospital-based cancer registries may be necessary.

Original languageEnglish
Pages (from-to)72-76
Number of pages5
JournalJapanese Journal of Lung Cancer
Volume52
Issue number1
DOIs
Publication statusPublished - 2012 Feb
Externally publishedYes

Fingerprint

Quality of Health Care
Registries
Lung Neoplasms
Medical Records
Japan
Neoplasms
Documentation
Databases
State Government
Cancer Care Facilities
Benchmarking
Neoplasm Staging
Quality Improvement
Practice Guidelines
Radiotherapy
Drug Therapy
Therapeutics
Research

Keywords

  • Lung cancer registry
  • Modified-Delphi method
  • Quality improvement quality indicator
  • Quality of care

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine

Cite this

Quality indicators and the Japanese lung cancer registry. / Higashi, Takahiro; Asamura, Hisao.

In: Japanese Journal of Lung Cancer, Vol. 52, No. 1, 02.2012, p. 72-76.

Research output: Contribution to journalArticle

@article{6671e7d878154fc181acc4758e66f613,
title = "Quality indicators and the Japanese lung cancer registry",
abstract = "Quality of care has been recognized as a national issue in Japan, particularly in the area of cancer care. The Cancer Control Act of 2006 states that the government should take action to assure quality of care throughout Japan. The Interim Report on the Cancer Control Plan, published in 2010, reviewed current activities and stated the need for a Quality Benchmarking Center to monitor the quality of cancer care using process-of-care quality indicators derived from clinical practice guidelines. Recognizing this national concern, a research project is under way to develop process-of-care quality indicators for 5 major types of cancer in Japan, including lung cancer. The process involved the identification of potential quality indicators and the examination of their validity using the modified Delphi method by a panel of multidisciplinary clinical experts. For lung cancer, this process produced 35 quality indicators covering a broad range of care, including pre-treatment evaluation, surgical treatment chemotherapy and radiation therapy. Although these quality indicators are designed to be implemented based on medical records, some quality indicators were apparently scorable using data from the Japanese Lung Cancer Registry operated by the Japanese Joint Committee for Lung Cancer Registry. If such usage is possible, systematic quality monitoring and feedback could be provided to the participating facility in order to improve quality of care. Further, feedback on care quality in an individual hospital, without disclosing the information to a third party can be regarded as a benefit of participation. However, detailed examination revealed that 6 out of 7 quality indicators that appeared to be theoretically scorable using registry data examined the presence/absence of the documentation of necessary clinical information in patient medical records. Therefore, for the scores to validly represent quality, we must assume that the existence of information in the examined data sets means that the pertinent documentation is also present in the medical records. Because we do not know whether this assumption is reasonable, we concluded that the current database is insufficient for quality of care monitoring. The current Lung Cancer Registry primarily aims to provide data to determine the TNM staging system, limiting the extent of available information in order to avoid placing an excessive burden on participating institutions. If we are to expand its scope to include quality improvement of lung cancer care in the future, the linking of data with other systems such as administrative databases and hospital-based cancer registries may be necessary.",
keywords = "Lung cancer registry, Modified-Delphi method, Quality improvement quality indicator, Quality of care",
author = "Takahiro Higashi and Hisao Asamura",
year = "2012",
month = "2",
doi = "10.2482/haigan.52.72",
language = "English",
volume = "52",
pages = "72--76",
journal = "Japanese Journal of Lung Cancer",
issn = "0386-9628",
publisher = "Japan Lung Cancer Society",
number = "1",

}

TY - JOUR

T1 - Quality indicators and the Japanese lung cancer registry

AU - Higashi, Takahiro

AU - Asamura, Hisao

PY - 2012/2

Y1 - 2012/2

N2 - Quality of care has been recognized as a national issue in Japan, particularly in the area of cancer care. The Cancer Control Act of 2006 states that the government should take action to assure quality of care throughout Japan. The Interim Report on the Cancer Control Plan, published in 2010, reviewed current activities and stated the need for a Quality Benchmarking Center to monitor the quality of cancer care using process-of-care quality indicators derived from clinical practice guidelines. Recognizing this national concern, a research project is under way to develop process-of-care quality indicators for 5 major types of cancer in Japan, including lung cancer. The process involved the identification of potential quality indicators and the examination of their validity using the modified Delphi method by a panel of multidisciplinary clinical experts. For lung cancer, this process produced 35 quality indicators covering a broad range of care, including pre-treatment evaluation, surgical treatment chemotherapy and radiation therapy. Although these quality indicators are designed to be implemented based on medical records, some quality indicators were apparently scorable using data from the Japanese Lung Cancer Registry operated by the Japanese Joint Committee for Lung Cancer Registry. If such usage is possible, systematic quality monitoring and feedback could be provided to the participating facility in order to improve quality of care. Further, feedback on care quality in an individual hospital, without disclosing the information to a third party can be regarded as a benefit of participation. However, detailed examination revealed that 6 out of 7 quality indicators that appeared to be theoretically scorable using registry data examined the presence/absence of the documentation of necessary clinical information in patient medical records. Therefore, for the scores to validly represent quality, we must assume that the existence of information in the examined data sets means that the pertinent documentation is also present in the medical records. Because we do not know whether this assumption is reasonable, we concluded that the current database is insufficient for quality of care monitoring. The current Lung Cancer Registry primarily aims to provide data to determine the TNM staging system, limiting the extent of available information in order to avoid placing an excessive burden on participating institutions. If we are to expand its scope to include quality improvement of lung cancer care in the future, the linking of data with other systems such as administrative databases and hospital-based cancer registries may be necessary.

AB - Quality of care has been recognized as a national issue in Japan, particularly in the area of cancer care. The Cancer Control Act of 2006 states that the government should take action to assure quality of care throughout Japan. The Interim Report on the Cancer Control Plan, published in 2010, reviewed current activities and stated the need for a Quality Benchmarking Center to monitor the quality of cancer care using process-of-care quality indicators derived from clinical practice guidelines. Recognizing this national concern, a research project is under way to develop process-of-care quality indicators for 5 major types of cancer in Japan, including lung cancer. The process involved the identification of potential quality indicators and the examination of their validity using the modified Delphi method by a panel of multidisciplinary clinical experts. For lung cancer, this process produced 35 quality indicators covering a broad range of care, including pre-treatment evaluation, surgical treatment chemotherapy and radiation therapy. Although these quality indicators are designed to be implemented based on medical records, some quality indicators were apparently scorable using data from the Japanese Lung Cancer Registry operated by the Japanese Joint Committee for Lung Cancer Registry. If such usage is possible, systematic quality monitoring and feedback could be provided to the participating facility in order to improve quality of care. Further, feedback on care quality in an individual hospital, without disclosing the information to a third party can be regarded as a benefit of participation. However, detailed examination revealed that 6 out of 7 quality indicators that appeared to be theoretically scorable using registry data examined the presence/absence of the documentation of necessary clinical information in patient medical records. Therefore, for the scores to validly represent quality, we must assume that the existence of information in the examined data sets means that the pertinent documentation is also present in the medical records. Because we do not know whether this assumption is reasonable, we concluded that the current database is insufficient for quality of care monitoring. The current Lung Cancer Registry primarily aims to provide data to determine the TNM staging system, limiting the extent of available information in order to avoid placing an excessive burden on participating institutions. If we are to expand its scope to include quality improvement of lung cancer care in the future, the linking of data with other systems such as administrative databases and hospital-based cancer registries may be necessary.

KW - Lung cancer registry

KW - Modified-Delphi method

KW - Quality improvement quality indicator

KW - Quality of care

UR - http://www.scopus.com/inward/record.url?scp=84860898431&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860898431&partnerID=8YFLogxK

U2 - 10.2482/haigan.52.72

DO - 10.2482/haigan.52.72

M3 - Article

VL - 52

SP - 72

EP - 76

JO - Japanese Journal of Lung Cancer

JF - Japanese Journal of Lung Cancer

SN - 0386-9628

IS - 1

ER -